Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-06-13 to 2024-06-14
Current total value of award: $8330.56
Description: 4564972480!ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML